IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity

Cancer Research

Volumn 69, Issue 16, 2009, Pages 6607-6614

  Pletneva, Maria ^a   Fan, Hongni ^a   Park, Jang June ^a   Radojcic, Vedran ^a   Jie, Chunfa ^b   Yu, Yanxing ^a   Chan, Camie ^c   Redwood, Alec ^d   Pardoll, Drew ^a   Housseau, Franck ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE MODEL; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 69249120194     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0508     Document Type: Article

References (39)

1. Chan CW, Crafton E, Fan HN, et al. Interferonproducing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006;12:207-13.
2. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006;12:214-9.
3. Pillarisetty VG, Katz SC, Bleier JI, Shah AB, Dematteo RP. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-g via autocrine IL-12. J Immunol 2005;174:2612-8.
4. Spits H, Lanier LL. Natural killer or dendritic: What's in a name? Immunity 2007;26:11-6.
5. Vosshenrich CA, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007; 204:2569-78.
6. Blasius AL, Barchet W, Cella M, Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007; 204:2561-8.
7. Caminschi I, Ahmet F, Heger K, et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J ExpMed 2007;204:2579-90.
8. Welner RS, Pelayo R, Garrett KP, et al. Interferonproducing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood 2007;109: 4825-931.
9. Wang X, Messerle M, Sapinoro R, et al. Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol 2003;77:7182-92.
10. Mathys S, Schroeder T, Ellwart J, Koszinowski UH, Messerle M, Just U. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis 2003; 187:988-99.
11. Lloyd ML, Shellam GR, Papadimitriou JM, Lawson MA. Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod 2003;68:2024-32.
12. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997;6:715-26.
13. Bryant P, Ploegh H. Class II MHC peptide loading by the professionals. Curr Opin Immunol 2004;16:96-102.
14. Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the MHC class I peptide loading complex. Immunol Rev 1999;172:21-8.
15. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007;315:107-11.
16. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003;299:1400-3.
17. Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pHto regulate antigen processing during crosspresentation by dendritic cells. Cell 2006;126: 205-18.
18. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005; 23:975-1028.
19. Burgdorf S, Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 2008;20:89-95.
20. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
21. Himoudi N, Yan M, Bouma G, et al. Migratory and antigen presentation functions of IFN-producing killer dendritic cells. Cancer Res 2009;69:6598-606.
22. + subset and are liceased by tumor cells. Cancer Res 2009;69:6590-7.
23. Hanna J, Gonen-Gross T, Fitchett J, et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004;114:1612-23.
24. Saudemont A, Jouy N, Hetuin D, Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-1 that stimulates T cells. Blood 2005;105:2428-35.
25. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-Talk between activated human NK cells and CD4+ T cells via OX40-40 ligand interactions. J Immunol 2004;173:3716-24.
26. Chan CW, Housseau F. The 'kiss of death' by dendritic cells to cancer cells. Cell Death Differ 2008; 15:58-69.
27. Spits H, Yssel H, Takebe Y, et al. Recombinant interleukin 4 promotes the growth of human T cells. J Immunol 1987;139:1142-7.
28. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
29. Beauvillain C, Delneste Y, Scotet M, et al. Neutrophils efficiently cross-prime naive T cells in vivo. Blood 2007; 110:2965-73.
30. Hoeffel G, Ripoche AC, Matheoud D, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007;27:481-92.
31. Potter NS, Harding CV. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J Immunol 2001;167:2538-46.
32. Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 2005;175: 2071-81.
33. Roncarolo MG, Bigler M, Haanen JB, et al. Natural killer cell clones can efficiently process and present protein antigens. J Immunol 1991;147:781-7.
34. Plitas G, Chaudhry UI, Kingham TP, Raab JR, DeMatteo RP. NK dendritic cells are innate immune responders to Listeria monocytogenes infection. J Immunol 2007;178:4411-6.
35. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural killer cells and dendritic cells: "l'union fait la force". Blood 2005;106:2252-8.
36. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007;13:54-61.
37. Goldberg MV, Maris CH, Hipkiss EL, et al. Role of PD-1 and its ligand, B71, in early fate decisions of CD8 T cells. Blood 2007;110:186-92.
38. Papewalis C, Jacobs B, Wuttke M, et al. IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol 2008;180:1462-70.
39. Stary G, Bangert C, Tauber M, Strohal R, Kopp T, Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 2007;204: 1441-51.